← Leaderboards
Christopher Gelbmann
University Of Wisconsin-Madison
$84,299
Attributed
$84,299
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2018–19$50K$37.5K$25K$12.5K$0
'18
'19
Funding mix
By agency
NIH$84,299 · 1
By mechanism
F30$84,299 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Robert F Kalejta$11,761,648
- Rupa Sridharan$4,639,708
- Donna M Neumann$3,267,077
- Maiken Nedergaard$36,611,904
- Marta Maria Gaglia$3,662,438
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAids/Hiv ProblemArchitectureCell NucleusCell SurfaceCellular TargetingCombatCytomegalovirusEarly PromotersEpidermal Growth Factor ReceptorFibroblastsGenesGolgi ApparatusHistone Deacetylase InhibitorHistone DemethylaseHistone ModificationHuman PathogenImmuneImmune SystemImmunocompromised HostInfectionLatent InfectionLeadAbcc1 Gene
Grant awards (2)
Elucidating the mechanism of UL138 mediated suppression of lytic phase genes during human cytomegalovirus latency.$49,511
F30 · FY2019 · AI · contact PI
Elucidating the mechanism of UL138 mediated suppression of lytic phase genes during human cytomegalovirus latency.$34,788
F30 · FY2018 · AI · contact PI